Free Trial

Pekin Hardy Strauss Inc. Makes New Investment in Healthcare Realty Trust Incorporated (NYSE:HR)

Healthcare Realty Trust logo with Finance background

Pekin Hardy Strauss Inc. acquired a new position in shares of Healthcare Realty Trust Incorporated (NYSE:HR - Free Report) in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm acquired 21,000 shares of the real estate investment trust's stock, valued at approximately $355,000.

Several other hedge funds have also bought and sold shares of HR. Proficio Capital Partners LLC acquired a new stake in Healthcare Realty Trust in the 4th quarter valued at $440,000. Smartleaf Asset Management LLC grew its position in Healthcare Realty Trust by 59.0% in the 4th quarter. Smartleaf Asset Management LLC now owns 1,650 shares of the real estate investment trust's stock valued at $27,000 after purchasing an additional 612 shares during the period. Jones Financial Companies Lllp grew its position in Healthcare Realty Trust by 68.7% in the 4th quarter. Jones Financial Companies Lllp now owns 3,067 shares of the real estate investment trust's stock valued at $52,000 after purchasing an additional 1,249 shares during the period. Steward Partners Investment Advisory LLC lifted its stake in Healthcare Realty Trust by 3,419.8% during the 4th quarter. Steward Partners Investment Advisory LLC now owns 28,510 shares of the real estate investment trust's stock valued at $483,000 after acquiring an additional 27,700 shares in the last quarter. Finally, M&T Bank Corp lifted its stake in Healthcare Realty Trust by 6.3% during the 4th quarter. M&T Bank Corp now owns 44,219 shares of the real estate investment trust's stock valued at $749,000 after acquiring an additional 2,616 shares in the last quarter.

Healthcare Realty Trust Price Performance

HR stock traded down $0.11 during mid-day trading on Friday, reaching $16.09. 7,007,350 shares of the company traded hands, compared to its average volume of 3,180,292. The company has a market capitalization of $5.65 billion, a P/E ratio of -14.76 and a beta of 0.89. Healthcare Realty Trust Incorporated has a 52-week low of $14.09 and a 52-week high of $18.90. The company has a fifty day moving average price of $15.06 and a 200-day moving average price of $15.94.

Healthcare Realty Trust (NYSE:HR - Get Free Report) last posted its earnings results on Thursday, May 1st. The real estate investment trust reported $0.39 earnings per share for the quarter, meeting analysts' consensus estimates of $0.39. The business had revenue of $288.86 million during the quarter, compared to analyst estimates of $297.39 million. Healthcare Realty Trust had a negative return on equity of 7.06% and a negative net margin of 31.32%. The company's quarterly revenue was down 9.2% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.39 EPS. As a group, analysts forecast that Healthcare Realty Trust Incorporated will post 1.59 EPS for the current year.

Healthcare Realty Trust Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, May 23rd. Investors of record on Monday, May 12th were given a $0.31 dividend. This represents a $1.24 annualized dividend and a dividend yield of 7.71%. The ex-dividend date was Monday, May 12th. Healthcare Realty Trust's dividend payout ratio (DPR) is -113.76%.

Analysts Set New Price Targets

HR has been the topic of several recent analyst reports. Wall Street Zen cut Healthcare Realty Trust from a "hold" rating to a "sell" rating in a research note on Saturday, May 31st. Wedbush lowered their price objective on Healthcare Realty Trust from $18.00 to $16.00 and set a "neutral" rating on the stock in a research note on Monday, May 5th. Wells Fargo & Company lowered their price objective on Healthcare Realty Trust from $16.00 to $15.00 and set an "underweight" rating on the stock in a research note on Monday, June 2nd. Finally, JPMorgan Chase & Co. lowered their price objective on Healthcare Realty Trust from $18.00 to $17.00 and set a "neutral" rating on the stock in a research note on Thursday, June 26th. Two equities research analysts have rated the stock with a sell rating and four have issued a hold rating to the company. According to MarketBeat.com, the company has an average rating of "Hold" and an average price target of $16.40.

Get Our Latest Stock Analysis on Healthcare Realty Trust

Insider Buying and Selling at Healthcare Realty Trust

In related news, Director Thomas N. Bohjalian acquired 2,500 shares of the firm's stock in a transaction that occurred on Tuesday, May 13th. The shares were bought at an average cost of $14.71 per share, for a total transaction of $36,775.00. Following the completion of the transaction, the director owned 56,502 shares in the company, valued at approximately $831,144.42. This trade represents a 4.63% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 0.37% of the company's stock.

Healthcare Realty Trust Profile

(Free Report)

Healthcare Realty Trust, Inc provides real estate investment services. It owns, leases, manages, acquires, finances, develops, and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States of America. The company was founded by David R.

Featured Articles

Institutional Ownership by Quarter for Healthcare Realty Trust (NYSE:HR)

Should You Invest $1,000 in Healthcare Realty Trust Right Now?

Before you consider Healthcare Realty Trust, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthcare Realty Trust wasn't on the list.

While Healthcare Realty Trust currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Hot Growth Stocks to Watch Right Now!
Don’t Miss These Top 3 Defense Stocks Set To Gain
Triple-Digit Gains: These 4 Nuclear Stocks Have Even More Upside Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines